A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Clinical trial NCT06516510 · TERMINATED

Trial details

NCT number: NCT06516510
Sponsor: Blue Earth Therapeutics Ltd
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2024-10-31
Primary completion: 2025-08-15
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.